Physician profile
Manuel Martinez
NPI 1700800547
$26,016.80
in general payments reported to CMS, 2019-2025
9 companies · $34.57 in 2025
The $34.57 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25K · 2021: $550 · 2022: $550 · 2023: $22.05 · 2024: $119 · 2025: $34.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien Lp | $24,725.00 | 2020 | |
| Medtronic, INC. | $1,100.00 | 2021-2022 | |
| Steris Corporation | $42.49 | 2024 | |
| Endogastric Solutions, INC | $35.03 | 2024 | Esophyx |
| Madrigal Pharmaceuticals | $34.57 | 2025 | Rezdiffra |
| Erbe USA INC | $25.00 | 2024 | Vio3 |
| Olympus America INC. | $22.05 | 2023 | Visiglide |
| Conmed Corporation | $16.33 | 2024 | Conmed Biliary |
| Pentax of America, INC. | $16.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.